RefleXion Announces Licensing Agreement with Mirada Medical to Advance Personalized Cancer Treatment
Rapid, adaptive radiotherapy treatment plans hold potential to reduce toxicity and improve patient outcomes HAYWARD, Calif., July 7, 2022...
top of page
Apposite Capital Makes Further Investment in Mirada Medical to Advance Precision Cancer Care
London, UK – 8th June 2022. Apposite Capital, the healthcare specialist private equity investor, today announces that it has made a...
Sorna Corporation Now Offering PET/CT Fusion Viewer
EAGAN, MN – June 8, 2022– Sorna Corporation continues to innovate enterprise imaging with the announcement of its partnership with Mirada...
Pioneering Personalized Cancer Care – Article with Healthcare Tech
Mirada Medical Pioneering Personalized Cancer Care “Everybody’s cancer is unique, requiring a personalized and precise treatment,” says...
bottom of page